Prof Dennis Y M LO
Elected as ASHK Founding Member in 2015
SBS; MA (Cantab); DM, DPhil (Oxon); FRCP (Lond & Edin); FRCPath; FRS; Foreign Associate, US National Academy of Sciences;
Fellow, TWAS; Founding Member, The Hong Kong Academy of Sciences
Associate Dean (Research), Faculty of Medicine
Chairman of the Department of Chemical Pathology
Professor of Chemical Pathology
Director of the Li Ka Shing Institute of Health Sciences
Li Ka Shing Professor of Medicine
Prof Dennis Y M Lo is the Director of the Li Ka Shing Institute of Health Sciences, the Li Ka Shing Professor of Medicine and Professor of Chemical Pathology of The Chinese University of Hong Kong (CUHK). He is also the Associate Dean (Research) of the Faculty of Medicine of CUHK. Professor Lo received his Bachelor of Arts degree from the University of Cambridge and the Doctor of Medicine and Doctor of Philosophy degrees from the University of Oxford.
Prof Lo joined CUHK in 1997. In the same year, he discovered the presence of cell-free fetal DNA in maternal plasma. He and his colleagues are instrumental in making non-invasive DNA-based prenatal testing a clinical reality. His team has developed a Down syndrome test that has been adopted in over 90 countries and has been used by over two million pregnant women. With the use of massively parallel sequencing and the development of novel bioinformatics strategies, Professor Lo’s group succeeded in deciphering a genome-wide genetic map of the fetus through the analysis of traces of fragmented DNA floating in the blood of pregnant women. This scientific achievement lays the foundation for developing non-invasive prenatal diagnostic tests for multiple genetic diseases.
In recognition of his work, Prof Lo has been the recipient of numerous awards, including the 2005 State Natural Science Award from the State Council of China, the 2006 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) – Abbott Award for Outstanding Contribution to Molecular Diagnostics, the 2006 US National Academy of Clinical Biochemistry Distinguished Scientist Award, the 2006 Croucher Senior Medical Research Fellowship, the 2007 American Association for Clinical Chemistry (AACC) Sigi Ziering Award, Fulbright Distinguished Scholar 2009, the 2012 AACC-NACB Award for Outstanding Contributions To Clinical Chemistry in a Selected Area of Research, the 2014 King Faisal International Prize for Medicine, the 2015 Pioneer Award at the Personalized Medicine World Conference, Silicon Valley, the 2015 AACC Wallace H. Coulter Lectureship Award and The 2021 Breakthrough Prize in Life Sciences. He was elected as a Fellow of the Royal Society in 2011, as a Foreign Associate of the US National Academy of Sciences in 2013, and as a Fellow of The World Academy of Sciences in 2013.